Xiaobao Xu, Ph.D.

626-218-2975

Postdoctoral Fellow, Department Of Systems Biology

Research Area

Precision Medical With Single Cell Detection And Imaging

Investigation Of Epigenetics By Using CRISPR-CAS9

Immunotherapy And Mechanism Of Immune System Respond To Inflammation

Research Teams

Systems Biology

Dr. Xiaobao Xu obtained his Ph.D. degree from Zhejiang University, China. He is experienced in biomimicry drug self-delivery system based on red blood cells membrane, and immunotherapy based on combined checkpoint inhibitor with thermal therapy. Dr. Xu joined David Chen’s laboratory at the Department of Systems Biology in January 2019. His current projects focus on developing novel CRISPR-based systems for epigenome editing and cancer therapy

Education & Experience

Degrees

2014 - 2018, Ph.D., Biomedical Engineering, Zhejiang University, Hangzhou, P. R. China
2009 - 2012, M.S. Bioengineering, Guizhou University, Guiyang, P. R. China
2005 - 2009, B.S. Bioengineering, Guizhou University, Guiyang, P. R. China

Fellowship

2019 – Current, Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, CA

Professional Experience

2019 – present, Postdoctoral Fellow, Department of Systems Biology, City of Hope Beckman Research Institute, Monrovia, CA
2016-2018, Visiting Scholar, Department of Biochemistry and Molecular Medicine, Medical Center, University of California, Davis, CA
2014-2018, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, P. R. China

Publications

Xu X, Yang G, Xue X, et al(2018). A polymer-free, biomimicry drug self-delivery system fabricated via a synergistic combination of bottom-up and top-down approaches[J]. Journal of Materials Chemistry B, 6(47): 7842-7853.
XB. Xu, ed. Al. (2016) Metabolomic profile for the early detection of coronary artery disease by using UPLC-QTOF/MS.Journal of pharmaceutical and biomedical analysis, 129, 34-42.
XB.Xu,TX.Wu,QL.Tang.(2016)ChangesinGastrodiatuber,EthanolExtracts During Grifola frondosa, Fermentation. Chemistry of Natural Compounds, 52(1):74-77.
XD. Xue, Yee. Huang, RN. Bo, B. Jia, H. Wu, Y. Yuan, ZL. Wang, Z. Ma, D. Jing, XB. Xu, et al. (2018) Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nature Communications, DOI: 10.1038/s41467-018-06093-5.
W. Zhu, XB. Xu, JK. Tian, et al.(2015) Proteomic Analysis of Lonicera japonica Thunb. Immature Flower Buds using Combinatorial Peptide Ligand Libraries and Polyethylene Glycol Fractionation. Journal of Proteome Research.